Name | Imatinib (STI571) | CAS# | 152459-95-5 | |
---|---|---|---|---|
Price | ¥Inquiry/1g | Purity | 98.9% | |
Stocking Period |
1 Day | Stock | In Stock |
Detail
Product Information
Imatinib is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM, respectively. Imatinib is used to treat chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs) and a number of other malignancies. |
Get all suppliers by the below link:
2024-07-15 |
Imatinib (STI571)
Price: Inquiry |
2019-03-05 |
Imatinib (STI571)
Price: ¥108.0 |
2020-03-08 |
Imatinib(free base)
Price: $200.0 |
2024-01-09 |
Imatinib
Price: $Inquiry |
2025-01-03 |
Imatinib (STI571)
Price: ¥Inquiry |
2017-06-15 |
Imatinib (STI571)
Price: ¥Inquiry |
2017-09-12 |
Imatinib (STI571)
Price: ¥220.0 |
2017-12-11 |
Imatinib (STI571)
Price: ¥Inquiry |
2018-04-15 |
Imatinib
Price: ¥Inquiry |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved